Jürgen Behr Selected Research

Vascular Diseases (Vascular Disease)

1/2021	Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
9/2017	Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Behr Research Topics

Disease

29	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 04/2014
28	Idiopathic Pulmonary Fibrosis 11/2023 - 01/2008
19	Pulmonary Hypertension 11/2023 - 08/2002
15	Fibrosis (Cirrhosis) 10/2022 - 08/2004
12	Asthma (Bronchial Asthma) 03/2024 - 04/2014
12	Lung Diseases (Lung Disease) 11/2023 - 04/2008
10	Disease Progression 09/2022 - 01/2008
9	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2023 - 04/2013
9	Infections 01/2022 - 11/2014
7	COVID-19 01/2023 - 12/2020
5	Pulmonary Arterial Hypertension 07/2023 - 10/2005
5	Emphysema 01/2022 - 01/2015
5	Familial Primary Pulmonary Hypertension 12/2011 - 08/2002
4	Neoplasms (Cancer) 09/2023 - 01/2020
4	Hypertension (High Blood Pressure) 11/2022 - 04/2011
4	Dyspnea (Shortness of Breath) 01/2019 - 08/2002
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 09/2018 - 01/2012
3	Inflammation (Inflammations) 01/2023 - 08/2013
3	Heart Diseases (Heart Disease) 01/2022 - 02/2007
3	Pneumonia (Pneumonitis) 01/2021 - 01/2019
3	Bronchiolitis Obliterans Syndrome 09/2018 - 05/2003
2	Airway Obstruction (Choking) 11/2023 - 01/2023
2	Connective Tissue Diseases (Connective Tissue Disease) 07/2023 - 01/2021
2	Pneumothorax 05/2023 - 01/2009
2	Hyperlipidemias (Hyperlipidemia) 11/2022 - 01/2017
2	Heart Failure 02/2022 - 01/2017
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 07/2021
2	Cytomegalovirus Infections (Inclusion Disease) 10/2021 - 01/2020
2	Vascular Diseases (Vascular Disease) 01/2021 - 09/2017
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2016
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2021 - 09/2017
2	Nausea 01/2021 - 01/2020
2	Lung Injury 01/2020 - 10/2004
2	Idiopathic Interstitial Pneumonias 01/2019 - 01/2017
2	Clinical Deterioration 01/2016 - 08/2002
2	Shock 04/2015 - 10/2014
2	Starvation 07/2014 - 03/2006
1	Obstructive Lung Diseases (Obstructive Lung Disease) 04/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024
1	Stroke (Strokes) 04/2024
1	Myocardial Infarction 04/2024

Drug/Important Bio-Agent (IBA)

18	GoldIBA 03/2024 - 04/2014
12	pirfenidoneIBA 01/2023 - 01/2016
10	Biomarkers (Surrogate Marker)IBA 02/2023 - 10/2016
8	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 01/2021
8	Oxygen (Dioxygen)IBA 01/2023 - 01/2012
7	nintedanibIBA 10/2022 - 01/2017
6	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
6	Sildenafil Citrate (Viagra)FDA Link 01/2021 - 02/2004
5	Carbon MonoxideIBA 01/2023 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2017
5	RNA (Ribonucleic Acid)IBA 06/2022 - 10/2014
5	CollagenIBA 01/2021 - 08/2015
5	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2019 - 03/2004
5	Endothelin Receptor AntagonistsIBA 12/2018 - 03/2005
5	Iloprost (Ventavis)FDA Link 12/2011 - 08/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024 - 02/2004
4	Monoclonal AntibodiesIBA 03/2024 - 05/2003
4	CytokinesIBA 01/2023 - 08/2013
4	riociguatIBA 02/2022 - 04/2013
3	dupilumabIBA 03/2024 - 01/2020
3	EnzymesIBA 01/2023 - 01/2016
3	SmokeIBA 01/2023 - 01/2016
3	Interleukin-5 (Interleukin 5)IBA 01/2023 - 01/2021
3	ProteomeIBA 01/2022 - 03/2006
3	SteroidsIBA 01/2021 - 01/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 01/2016
3	AcidsIBA 09/2018 - 03/2006
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 01/2012
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2005 - 08/2002
2	benralizumabIBA 03/2024 - 01/2021
2	mepolizumabIBA 03/2024 - 01/2021
2	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 12/2022
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 12/2022 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2016
2	Tacrolimus Binding Proteins (FKBP)IBA 01/2022 - 08/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2021
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 08/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 06/2009
2	letermovirIBA 10/2021 - 01/2020
2	AntibodiesIBA 07/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2005
2	AsbestosIBA 01/2021 - 09/2017
2	anti-IgE antibodiesIBA 01/2021 - 12/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2019 - 12/2018
2	Transfer Factor (Factor, Transfer)IBA 01/2019 - 01/2017
2	ProstaglandinsIBA 12/2018 - 12/2011
2	AerosolsIBA 03/2015 - 10/2003
2	Vasodilator Agents (Vasodilators)IBA 08/2013 - 02/2004
2	Bosentan (Tracleer)FDA Link 01/2008 - 03/2005
1	BilirubinIBA 04/2024
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2024
1	AutoantigensIBA 11/2023

Therapy/Procedure

46	Therapeutics 03/2024 - 08/2002
11	Lung Transplantation 04/2024 - 05/2003
3	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2019
2	Transplantation 04/2024 - 01/2021
2	Biological Therapy 07/2021 - 12/2018
2	Noninvasive Ventilation 01/2021 - 01/2018
1	Percutaneous Coronary Intervention 04/2024